EUVIMEDEUVIMED entdecken
Crossref

2137-P: Distinct Intrauterine Programming Pathways for Prenatal Exposures to GDM and Maternal Obesity

ELLA C. MORGAN, MARGO SIDELL, TING CHOW, JASMIN ALVES, BRITNI BELCHER, ANNY XIANG, KATHLEEN PAGE

Diabetes · 05.06.2026 · 75 (Supplement_1)

DOI: 10.2337/db26-2137-p ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von ELLA C. MORGAN und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and Objective: Pathways for maternal obesity and GDM exposure to offspring diabetes are unclear. We examined whether these exposures differentially affect insulin sensitivity and secretion.

Methods

The BrainChild cohort did 3-hour OGTTs (n=212; age 8.7±1.1 years; 58% female; 102 GDM-exposed). Exposures were maternal pre-pregnancy BMI, GDM exposure (yes v. no), and timing (≤26 weeks, >26 weeks). Outcomes were insulin sensitivity (log whole body insulin sensitivity index (ISI) and secretion (log insulinogenic index at 30 minutes [InsIndex30]). Models adjusted for child age and sex, then further adjusted for % body fat (%BF); InsIndex30 also adjusted for ISI.

Results

Insulin Sensitivity: Maternal obesity was associated with lower ISI (β=−0.41, p=0.02), but this was fully attenuated after adjusting for child %BF (β=-0.01, p=0.97). Maternal overweight showed no association before (β=-0.22, p=0.25) or after adjustment (β=0.09, p=0.60). Overall GDM exposure was not associated with ISI (β=−0.18, p=0.21), but exposure ≤26 weeks was associated with lower ISI (β=−0.43, p=0.023); attenuated after adjustment for child %BF (β=-0.21, p=0.18). Exposure >26 weeks was not associated before (β=-0.02, p=0.91) or after child %BF adjustment (β=0.18, p=0.19). Insulin Secretion: Maternal pre-pregnancy weight was not associated with InsIndex30 (obesity: β=0.12, p=0.32; overweight: β=0.18, p=0.17). Further adjustment for %BF did not change the results. Overall GDM exposure was associated with lower InsIndex30 before (β=-0.17, p=0.08) and after adjusting for child %BF (β=−0.23, p=0.01); exposure ≤26 weeks was associated with lower InsIndex30 (β=−0.25, p=0.02); exposure >26 weeks was directionally similar but non-significant (β=-0.21, p=0.10).

Conclusion

Maternal obesity during pregnancy may influence child insulin sensitivity via increased adiposity. In contrast, GDM exposure is associated with impaired early-phase insulin secretion independent of adiposity and insulin sensitivity, supporting distinct intrauterine programming pathways. Disclosure E.C. Morgan: None. M. Sidell: None. T. Chow: None. J. Alves: None. B. Belcher: None. A. Xiang: None. K. Page: None. Funding American Diabetes Association (1-14-ACE-36), NIH (RO1DK116858, R01DK134079)

Zitieren

APA

MORGAN, E. C., SIDELL, M., CHOW, T., ALVES, J., BELCHER, B., XIANG, A., & PAGE, K. (2026). 2137-P: Distinct Intrauterine Programming Pathways for Prenatal Exposures to GDM and Maternal Obesity. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-2137-p

Vancouver

MORGAN EC, SIDELL M, CHOW T, ALVES J, BELCHER B, XIANG A, et al. 2137-P: Distinct Intrauterine Programming Pathways for Prenatal Exposures to GDM and Maternal Obesity. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-2137-p

BibTeX
@article{MORGAN2026,
  author = {MORGAN, ELLA C. and SIDELL, MARGO and CHOW, TING and ALVES, JASMIN and BELCHER, BRITNI and XIANG, ANNY and PAGE, KATHLEEN},
  title = {2137-P: Distinct Intrauterine Programming Pathways for Prenatal Exposures to GDM and Maternal Obesity},
  journal = {Diabetes},
  year = {2026},
  volume = {75},
  number = {Supplement_1},
  doi = {10.2337/db26-2137-p}
}
Kostenlos starten →